Two Sigma Investments
PALI icon

Two Sigma Investments’s Palisade Bio PALI Stock Holding History

Two Sigma Investments’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.4K Hold
27,640
– – ﹤0.01% 4455
2025
Q4 		$65K Buy
+27,640
New +$53.1K ﹤0.01% 3902
2023
Q1 		– Sell
-693
Closed -$54.1K – 3147
2022
Q4 		$54.1K Buy
693
+586
+548% +$34K ﹤0.01% 2581
2022
Q3 		$8K Buy
+107
New +$22.7K ﹤0.01% 2419
2022
Q2 		– Sell
-29
Closed -$23K – 2833
2022
Q1 		$23K Buy
29
+10
+53% +$8.08K ﹤0.01% 2522
2021
Q4 		$19K Buy
+19
New +$33.2K ﹤0.01% 4174

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Two Sigma Investments's PALI Position: Q1 2026 in Review

Two Sigma Investments held its Palisade Bio (PALI) position steady in Q1 2026 at 27,640 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4455.

Two Sigma Investments first reported a position in PALI in Q4 2021 and has held it in 6 quarters since. The position peaked at $65K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Two Sigma Investments held 27,640 shares of Palisade Bio worth $48.4K as of Q1 2026.
  • Two Sigma Investments left its Palisade Bio share count unchanged in Q1 2026.
  • Palisade Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4455 holding.
  • Two Sigma Investments first reported a position in Palisade Bio in Q4 2021 and has held it in 6 quarters since.
  • Two Sigma Investments's Palisade Bio position peaked at $65K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.